ATE377074T1 - Methode zur bereitstellung von dna sequenzen - Google Patents

Methode zur bereitstellung von dna sequenzen

Info

Publication number
ATE377074T1
ATE377074T1 AT97924928T AT97924928T ATE377074T1 AT E377074 T1 ATE377074 T1 AT E377074T1 AT 97924928 T AT97924928 T AT 97924928T AT 97924928 T AT97924928 T AT 97924928T AT E377074 T1 ATE377074 T1 AT E377074T1
Authority
AT
Austria
Prior art keywords
activity
interest
dna sequences
structural gene
hybrid
Prior art date
Application number
AT97924928T
Other languages
English (en)
Inventor
Henrik Dalboege
Boerge Diderichsen
Thomas Sandal
Sakari Kauppinen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Application granted granted Critical
Publication of ATE377074T1 publication Critical patent/ATE377074T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/248—Xylanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01032—Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT97924928T 1996-05-10 1997-05-12 Methode zur bereitstellung von dna sequenzen ATE377074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK56296 1996-05-10

Publications (1)

Publication Number Publication Date
ATE377074T1 true ATE377074T1 (de) 2007-11-15

Family

ID=8094949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924928T ATE377074T1 (de) 1996-05-10 1997-05-12 Methode zur bereitstellung von dna sequenzen

Country Status (7)

Country Link
US (1) US6270968B1 (de)
EP (1) EP0898618B1 (de)
AT (1) ATE377074T1 (de)
AU (1) AU3025597A (de)
DE (1) DE69738254T2 (de)
DK (1) DK0898618T3 (de)
WO (1) WO1997043409A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1038008B1 (de) * 1997-12-16 2006-10-18 Genencor International, Inc. Verfahren zur herstellung egiii-ähnlicher enzyme
US6921655B1 (en) 1998-10-23 2005-07-26 Meiji Seika Kaisha, Ltd. Endoglucanases and cellulase preparations containing the same
JP2000253885A (ja) * 1999-03-11 2000-09-19 Jcr Pharmaceuticals Co Ltd 任意プライマーｐｃｒを用いるｄｎａ断片クローニング方法
US7977051B2 (en) 1999-04-10 2011-07-12 Danisco Us Inc. EGIII-like enzymes, DNA encoding such enzymes and methods for producing such enzymes
DE10001140C2 (de) * 2000-01-13 2003-06-12 Gsf Forschungszentrum Umwelt Oligonukleotide zur Amplifikation und zum Nachweis von bakteriellen Genen für extrazelluläre alkalische Metallopeptidasen (Apr), neutrale Metallopeptidasen (Npr) und Serinpeptidasen (Spr)
ES2575526T3 (es) * 2003-12-03 2016-06-29 Meiji Seika Pharma Co., Ltd. Endoglucanasa STCE y preparación de celulasa que contiene la misma
EP2330199B1 (de) * 2003-12-08 2015-04-08 Meiji Seika Pharma Co., Ltd. Tensidtolerante Zellulase und Modifikationsverfahren dafür
EP1612267A1 (de) * 2004-07-02 2006-01-04 GBF Gesellschaft für Biotechnologische Forschung mbH Zellulasen aus Rumen
BRPI0609906A8 (pt) * 2005-04-29 2017-11-21 Ab Enzymes Oy proteína de fusão de celulase, seu processo de produção e composição detergente contendo a mesma, vetor de expressão, célula hospedeira, preparação de enzima, processos para desbotamento e para bioacabamento e métodos de tratamento de fibra celulósica contendo material têxtil, para tratar fibra ou polpa derivada de madeira e para melhorar a qualidade de ração animal
US7741093B2 (en) 2005-04-29 2010-06-22 Ab Enzymes Oy Cellulases and their uses
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
ES2561427T3 (es) 2008-12-23 2016-02-26 Dupont Nutrition Biosciences Aps Polipéptidos con actividad de xilanasa
AU2010270714B2 (en) 2009-07-06 2015-08-13 Wave Life Sciences Ltd. Novel nucleic acid prodrugs and methods use thereof
US10428019B2 (en) 2010-09-24 2019-10-01 Wave Life Sciences Ltd. Chiral auxiliaries
DK2734208T3 (en) 2011-07-19 2017-06-19 Wave Life Sciences Ltd PROCEDURES FOR SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS
SG11201500232UA (en) 2012-07-13 2015-04-29 Wave Life Sciences Pte Ltd Chiral control
US9598458B2 (en) 2012-07-13 2017-03-21 Wave Life Sciences Japan, Inc. Asymmetric auxiliary group
JP6246121B2 (ja) 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
EP3095460A4 (de) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chirales nukleinsäureadjuvans mit antiallergischer wirkung und antiallergikum
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10160969B2 (en) 2014-01-16 2018-12-25 Wave Life Sciences Ltd. Chiral design
EP3390625B1 (de) 2015-12-18 2023-09-06 Danisco US Inc. Polypeptide mit endoglucanaseaktivität und verwendungen davon
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2919890B2 (ja) * 1988-11-11 1999-07-19 メディカル リサーチ カウンスル 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用
US5780225A (en) * 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
DK115890D0 (da) * 1990-05-09 1990-05-09 Novo Nordisk As Enzym
ES2068586T5 (es) * 1990-05-09 2004-12-01 Novozymes A/S Una preparacion de celulasa que comprende una enzima endoglucanasa.
MX9206979A (es) * 1991-12-04 1993-07-01 Novo Nordisk As Metodo de clonacion de proteinas en levaduras
US5364787A (en) * 1992-03-23 1994-11-15 Idaho Research Foundation Genes and enzymes involved in the microbial degradation of pentachlorophenol
EP0663950B1 (de) * 1992-10-06 2004-03-17 Novozymes A/S Zellulosevarianten
CN102080070B (zh) * 1995-03-17 2016-01-20 诺沃奇梅兹有限公司 新的内切葡聚糖酶
CA2232709C (en) * 1995-09-22 2002-11-19 Terragen Diversity Inc. Method for isolating xylanase gene sequences from soil dna, compositions useful in such method and compositions obtained thereby

Also Published As

Publication number Publication date
WO1997043409A3 (en) 1998-02-26
AU3025597A (en) 1997-12-05
DE69738254T2 (de) 2008-08-14
DE69738254D1 (de) 2007-12-13
DK0898618T3 (da) 2008-02-25
EP0898618B1 (de) 2007-10-31
EP0898618A2 (de) 1999-03-03
US6270968B1 (en) 2001-08-07
WO1997043409A2 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
ATE377074T1 (de) Methode zur bereitstellung von dna sequenzen
WO1998050554A3 (en) Enterococcus faecalis polynucleotides and polypeptides
DK15182A (da) Fremgangsmaade til fremstilling af recombinant-dna
MX9705961A (es) Polimerasa de adn termoestable, modificada.
WO2001009301A3 (en) Nucleic acids and polypeptides of invertebrate twik channels and methods of use
ATE400651T1 (de) Verwendung von grünem fluoreszenzprotein
WO1999036516A3 (en) Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
EP1323728A3 (de) Verfahren zur Erstellung eines Standard Gen Transkriptions Musters für die Diagnostik
AU3365095A (en) High throughput screening method for sequences or genetic alterations in nucleic acids
AU4965499A (en) Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation
ATE79474T1 (de) Verfahren zum in vitro-nachweis und bestimmung unbekannter pathogene oder genetischer einheiten.
SE8801070D0 (sv) Method for immobilizing a dna sequence on a solid support
DE60220025D1 (de) Methoden und zusammensetzungen zur vervielfältigung von rna sequenzen
DE69432419D1 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
WO2002066622A3 (en) Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
ATE360688T1 (de) Dna-fragment, dieses enthaltender rekombinanter vektor und verfahren zur expression von fremdgenen unter dessen verwendung
ES2061536T3 (es) Procedimiento para la obtencion de glucosa dehidrogenasa a partir de bacillus megaterium.
DE69632963D1 (de) Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung
EP2281892A3 (de) Verfahren zur Herstellung von Polypeptiden in atmungsdefizienten Trichoderma Zellen
KR960017845A (ko) 부위-지정 변이유발방법
TW329476B (en) Method for detecting contaminant DNA in a protein product and kits used for the same purpose
ATE211180T1 (de) Verfahren zur nicht-radioaktiven detektion von membran-gebundenen nukleinsäuren und testkit
EP0904283A4 (de) Menschliches netrin-1
WO2002029101A3 (en) Methods for cloning, sequencing and expressing genes from complex microbial populations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties